Close X
Saturday, November 16, 2024
ADVT 
National

Vancouver's B2Gold Reports Q2 Net Loss On Increased Gold Production

The Canadian Press Darpan, 15 Aug, 2014 02:28 PM
    VANCOUVER - B2Gold Corp. says it's expecting another solid year for gold production while reporting about a four per cent increase in its second quarter.
     
    The Vancouver gold miner expects production in 2014 to be in the range of 395,000 to 420,000 ounces of gold with consolidated cash operating costs of $667 to $695 per ounce, similar to 2013 production.
     
    For the second-quarter, consolidated gold production in the quarter was 85,704 ounces, up from 82,083 ounces year-over-year.
     
    B2Gold reported a quarterly net loss of $11.5 million, or a loss of two cents per share, compared with net income of $33.1 million, or five cents per share, in the same quarter of 2013 which included a $44.5 million gain related to a royalty sale.
     
    Excluding one-time items, adjusted net income was $2.1 million, or no earnings per share, compared with $7.8 million, or one cent per share, in the same period of 2013.
     
    Gold revenue for the quarter was at $120.3 million on sales of 93,330 ounces at an average realized price of $1,289 per ounce. That compares with $122.6 million on sales of 86,239 ounces at an average realized price of $1,422 per ounce in the second quarter of 2013.
     
    In the quarter, B2Gold announced it would buy Australia's Papillon Resources in an all-stock deal worth about US$570 million. Papillon is an emerging gold developer in West Africa.
     
    B2Gold Corp. (TSX:BTO) has three operating mines, two in Nicaragua and one in the Philippines, and a portfolio of development and exploration assets in Nicaragua, Colombia, Namibia and Uruguay.
     
    Note to readers: This is a corrected story. A previous version moved Aug. 14 gave an incorrect description of Papillon.

    MORE National ARTICLES

    OmniTrax backs away from controversial plan to ship crude oil through Hudson Bay

    OmniTrax backs away from controversial plan to ship crude oil through Hudson Bay
    A rail company is putting the brakes on a controversial plan to haul millions of litres of crude oil across its northern rail line to the port of Churchill on Hudson Bay.

    OmniTrax backs away from controversial plan to ship crude oil through Hudson Bay

    Mayor Rob Ford's handling of bomb threat violated city policy: union

    Mayor Rob Ford's handling of bomb threat violated city policy: union
    The union representing Toronto city hall employees says Mayor Rob Ford's decision to report a bomb threat to the media violated city policy, putting workers at risk.

    Mayor Rob Ford's handling of bomb threat violated city policy: union

    Additional shipment of Canadian aid on its way to Ukraine, says Baird

    Additional shipment of Canadian aid on its way to Ukraine, says Baird
    Foreign Affairs Minister John Baird says a third shipment of Canadian aid to Ukraine departs for Kyiv today aboard a CC-130J Hercules aircraft.

    Additional shipment of Canadian aid on its way to Ukraine, says Baird

    Oilsands, deepwater among riskiest energy plays in the world, report says

    Oilsands, deepwater among riskiest energy plays in the world, report says
    A new report says some of the world's costliest energy projects are in Alberta's oilsands and many could be cancelled without higher oil prices.

    Oilsands, deepwater among riskiest energy plays in the world, report says

    Canadian Press NewsAlert: Canada to help shuttle weapons into Iraq

    Canadian Press NewsAlert: Canada to help shuttle weapons into Iraq
    Canada is committing two cargo planes to move military supplies into northern Iraq as part of the international effort to bolster Kurdish forces in the embattled region.

    Canadian Press NewsAlert: Canada to help shuttle weapons into Iraq

    Use of untested drugs for Ebola should be limited to best candidates: WHO

    Use of untested drugs for Ebola should be limited to best candidates: WHO
    The World Health Organization is trying to dampen runaway enthusiasm in some quarters for trying a number of untested compounds to treat Ebola in West Africa.

    Use of untested drugs for Ebola should be limited to best candidates: WHO